Clinical Trial: Construction of a high-risk population identification and early screening pathway for pancreatic lesions based on the PANCREAS scale (China)

Posted On: 2026-08-21

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Construction of a high-risk population identification and early screening pathway for pancreatic lesions based on the PANCREAS scale'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130486

Registration Time: 2026/08/20

Type: Observational study

Primary Sponsor: Peking Union Medical College Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335486

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Construction of a high-risk population identification and early screening pathway for pancreatic lesions based on the PANCREAS scale (China)